IMP3 Is a Novel Prognostic Marker that Correlates with Colon Cancer Progression and Pathogenesis

Dawei Li MD PhD; Dongwang Yan MD PhD; Huamei Tang MD; Chongzhi Zhou MD PhD; Junwei Fan MD PhD; Shuxia Li MD PhD; Xiaoliang Wang MD PhD; Jun Xia MD PhD; Fei Huang MD; Guoqiang Qiu MD; Zhihai Peng MD PhD

首页> 外文期刊>Annals of Surgical Oncology >IMP3 Is a Novel Prognostic Marker that Correlates with Colon Cancer Progression and Pathogenesis

【24h】

IMP3 Is a Novel Prognostic Marker that Correlates with Colon Cancer Progression and Pathogenesis

机译：IMP3是与结肠癌进展和发病机制相关的新型预后标志物

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Insulin-like growth factor-II mRNA-binding protein 3 (IMP3) plays a vital role in carcinogenesis; however, its significance and prognostic value in colon cancer remain unclear.

机译：胰岛素样生长因子-II mRNA结合蛋白3（IMP3）在致癌过程中起着至关重要的作用。然而，其在结肠癌中的意义和预后价值仍不清楚。

著录项

来源
《Annals of Surgical Oncology》 |2009年第12期|3499-3506|共8页
作者
Dawei Li MD PhD; Dongwang Yan MD PhD; Huamei Tang MD; Chongzhi Zhou MD PhD; Junwei Fan MD PhD; Shuxia Li MD PhD; Xiaoliang Wang MD PhD; Jun Xia MD PhD; Fei Huang MD; Guoqiang Qiu MD; Zhihai Peng MD PhD;
展开▼
作者单位

Department of General Surgery Shanghai Jiaotong University Affiliated First People’s Hospital Shanghai People’s Republic of China;

Department of General Surgery Shanghai Jiaotong University Affiliated First People’s Hospital Shanghai People’s Republic of China;

Department of Pathology Shanghai Jiaotong University Affiliated First People’s Hospital Shanghai People’s Republic of China;

Department of General Surgery Shanghai Jiaotong University Affiliated First People’s Hospital Shanghai People’s Republic of China;

Department of General Surgery Shanghai Jiaotong University Affiliated First People’s Hospital Shanghai People’s Republic of China;

Department of Pathology Shanghai Jiaotong University Affiliated First People’s Hospital Shanghai People’s Republic of China;

Department of General Surgery Shanghai Jiaotong University Affiliated First People’s Hospital Shanghai People’s Republic of China;

Department of General Surgery Shanghai Jiaotong University Affiliated First People’s Hospital Shanghai People’s Republic of China;

Department of General Surgery Shanghai Jiaotong University Affiliated First People’s Hospital Shanghai People’s Republic of China;

Department of General Surgery Shanghai Jiaotong University Affiliated First People’s Hospital Shanghai People’s Republic of China;

Department of General Surgery Shanghai Jiaotong University Affiliated First People’s Hospital Shanghai People’s Republic of China;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. IMP3 is a novel prognostic marker that correlates with colon cancer progression and pathogenesis. [J] . Li D, Yan D, Tang Annals of surgical oncology . 2009,第12期

机译：IMP3是一种新型的预后标志物，与结肠癌的进展和发病机制相关。
2. External validation of IMP3 expression as an independent prognostic marker for metastatic progression and death for patients with clear cell renal cell carcinoma. [J] . Hoffmann NE, Sheinin Y, Lohse CM, Cancer: A Journal of the American Cancer Society . 2008,第7期

机译：IMP3表达的外部验证是透明细胞肾细胞癌患者转移进展和死亡的独立预后指标。
3. TIMP1 is a prognostic marker for the progression and metastasis of colon cancer through FAK-PI3K/AKT and MAPK pathway [J] . Guohe Song, Shifeng Xu, Hong Zhang, Journal of experimental & clinical cancer research : . 2016,第1期

机译：TIMP1是通过FAK-PI3K / AKT和MAPK途径进行的结肠癌进展和转移的预后标志物
4. COMBINED PHENOTYPE OF FOUR MARKERS IMPROVES PROGNOSTIC VALUE OF COLON CANCER PATIENTS [C] . Caiyun Liu, Like Qu, Xiaofang Xing, 2011 Asia-Pacific Conference of tumor biology and medicine . 2011

机译：四种标记物的联合表型可提高结肠癌患者的预后价值
5. Development of novel biomarkers in cancer: Detection of circulating miR-141 as a potential prognostic marker for prostate cancer. [D] . Gonzales, Jason Cadaoas. 2010

机译：癌症中新型生物标志物的开发：检测循环miR-141作为前列腺癌的潜在预后标志物。
6. External Validation of IMP3 Expression as an Independent Prognostic Marker for Metastatic Progression and Death for Patients With Clear Cell Renal Cell Carcinoma [O] . Nathan E. Hoffmann, Yuri Sheinin, Christine M. Lohse, -1

机译：IMP3表达作为透明细胞肾细胞癌患者转移进展和死亡的独立预后标志物的外部验证
7. TIMP1 is a prognostic marker for the progression and metastasis of colon cancer through FAK-PI3K/AKT and MAPK pathway [O] . Guohe Song, Shifeng Xu, Hong Zhang, 2016

机译：TIMP1是通过FAK-PI3K / AKT和MAPK途径进行的结肠癌进展和转移的预后标志物
8. SAMM50 Level as a Prognostic and/or Diagnostic Marker for Breast Cancer Development and Progression. [R] . Sharma, S. 2011

机译：samm50水平作为乳腺癌发展和进展的预后和/或诊断标志物。

IMP3 Is a Novel Prognostic Marker that Correlates with Colon Cancer Progression and Pathogenesis

摘要

著录项

相似文献

相关主题

期刊订阅